Skip to main content
Clinical Trials/NCT01102309
NCT01102309
Completed
Not Applicable

Clinical and Social-economic Impact Assessment of Robot-assisted Rehabilitation of the Upper Limb in Acute and Subacute Post-stroke Patients

Eremo Hospital, Arco1 site in 1 country27 target enrollmentOctober 2008

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Stroke
Sponsor
Eremo Hospital, Arco
Enrollment
27
Locations
1
Primary Endpoint
Frenchay Arm Test (FA-T)
Status
Completed
Last Updated
14 years ago

Overview

Brief Summary

The goal of this study is to determine if robot aided rehabilitation therapy can be equivalent to or more effective than conventional rehabilitation therapy at promoting functional recovery of the paretic upper limb in acute and subacute stroke patients.

Detailed Description

The study aims to test a robotic rehabilitation protocol which involves the use of a robotic device (NeReBot) as an alternative to the conventional rehabilitation treatment. NeReBot is a 3-degree-of-freedom robotic device, which can be programmed by the therapist to perform repetitive assistive movements (flexion and extension, adduction and abduction, pronation and supination, circular) of the upper limb (shoulder and elbow), combined with a visual and acoustic display. Acute and subacute stroke patients (≤20 days post-stroke) will be randomized into two groups with a procedure by a computer program: the experimental group (EG) and the control group (CG). Both groups will receive a total daily treatment time of 120 minutes for five days a week and for five weeks. The EG will perform the conventional functional rehabilitation (proprioceptive exercises, verticalization, gait training, paretic hand and wrist mobilization, without mobilizing the proximal paretic arm) and occupational therapy for 80 minutes a day, while the proximal paretic arm will be treated by NeReBot for 40 minutes a day. For the CG, NeReBot therapy is substituted by 40 minutes of conventional mobilization of the proximal paretic arm by the therapist.

Registry
clinicaltrials.gov
Start Date
October 2008
End Date
June 2011
Last Updated
14 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Eremo Hospital, Arco

Eligibility Criteria

Inclusion Criteria

  • recent unilateral single stroke (ischemic or hemorrhagic) verified by brain CT or MRI;
  • sufficient cognitive and language skills to understand the instructions of the operator (assessed by Modified Mini-Mental State Examination \> 21);
  • patients with upper limb paralysis (Motor Power score between 8 and 12);
  • written informed consent signed by the patient (or an authorized representative).

Exclusion Criteria

  • cardiovascular instability (severe uncontrolled hypertension, severe coronary artery disease, etc.) or orthopedic, or neurological conditions;
  • presence of multiple cerebrovascular lesions (usually the result of many ischemic episodes in the past);
  • early appearance of marked spasticity (≥ 3 according to Ashworth Scale);
  • joint pain or limited joint range of motion (ROM) of the upper limb that results in the inability to complete the protocol;
  • severe neuropsychologic impairment (global aphasia, severe attention deficit or neglect), affecting the patient's ability to follow instructions;

Outcomes

Primary Outcomes

Frenchay Arm Test (FA-T)

Time Frame: 7 months

Franchey Arm Test (FA-T) evaluates five activities of daily living: lifting and replacing of a glass, drawing a line with the use of a ruler, combing the hair, lifting and replacing of a cylinder \[5 cm long\], removing of a sprung clothes peg from a dowel and replacing it; 0 = worst score; 5 = best score).It reflects both hand and arm functions.

Motor-Functional Independence Measure (m-FIM)

Time Frame: 7 months

Motor-Functional Independent Measure (m-FIM) is a test to measure improvements in basic motor ADL, outcomes and the degree of self-care. The motor-FIM is a subsection of Functional Indipendence Measure that is an ordinal scale that assesses severity of motor disability, composed of 13-item motor subscale (including self-care, sphincter control, mobility, locomotion) with a scoring ranges between 13 and 91; each item envisages 7 levels of performance independence (7 is total independence, 1 is total dependence or unassessable).

Fugl-Meyer (FM-SEC and FM-WH)

Time Frame: 7 months

Fugl-Meyer (FM) assessment for measures of the motor impairment of the upper-limb; the test includes items related to movements of the shoulder, elbow, forearm (proximal arm), and wrist and hand (distal arm). The total scores range between 0 and 66. We considered the shoulder/elbow and coordination subsections (FM-SEC = 42/66 items) and the wrist/hand subsection (FM-WH = 24/66 items).

Secondary Outcomes

  • Fatigue Severity Scale (FSS)(7 months)
  • Upper-Motricity Index (upMI)(7 months)
  • Short Form 12(7 months)
  • Functional Independent Measure (FIM)(7 months)
  • Medical Research Council (MRC deltoid, biceps, triceps, wrist flexor, wrist extensor)(7 months)
  • Box and Block Test(7 months)
  • Modified Ashworth Scale (MAS)(7 months)
  • Trunk Control Test (TCT)(7 months)

Study Sites (1)

Loading locations...

Similar Trials